Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
56 participants
OBSERVATIONAL
2013-10-31
2016-07-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Using Affectionate Communication as a Response to Acute Stress
NCT00468572
Effectiveness of a Mindfulness and Compassion Intervention for Pregnant Women and Their Partners for the Prevention of Stress and Depression During Pregnancy and Breastfeeding
NCT03247491
Mother-infant Connection Strategy Program
NCT06237088
Investigation of Different Relaxation Techniques in Eliciting a Relaxation Response
NCT03592147
Stress Physiology and Intervention Feasibility Among First Responder Parents
NCT05875246
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
While the emotion regulation literature posits that reappraisal may be associated with decreased in physiological and psychological stress, this type of regulation strategy may be ineffective when interfacing with discrimination. The regulation strategy needs to be titrated to the stressor in order to be effective. These findings will have notable social, clinical, and psychological significance,
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* No medication for hypertensive or cardiovascular disease
* Not using beta blockers
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Massachusetts, Boston
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kymberlee O'Brien, PhD
Role: PRINCIPAL_INVESTIGATOR
Postdoctoral Research Fellow
Celia L Moore, PhD
Role: STUDY_DIRECTOR
Director of DSRC and Horizon Center
Edward Tronick, PhD
Role: STUDY_DIRECTOR
Director Child Development Unit
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Mass. Boston
Boston, Massachusetts, United States
University of Massachusetts, Boston, Child Development Unit
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013173
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.